The additional factors that contribute to the AMPK activation after combined treatment are increased cytokines in these animals, since Il1b, as obesity-related, and Il6, as a muscle energy sensor, contribute to increased AMPK activity [51,52]. Here, PRKAA1 is linked to obesity due to melanocortin 4 receptor deficiency.